Cargando…

Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy

With the improvement in cancer survival, long-term cardiotoxicity has become an area of increased interest. Various cancer therapies, including chemotherapy and radiation therapy can lead to cardiac toxicities with both acute and chronic manifestations. Awareness and early recognition can lead to im...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamo, Carine E, Bloom, Michelle Weisfelner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525792/
https://www.ncbi.nlm.nih.gov/pubmed/26309419
http://dx.doi.org/10.4137/CMC.S19704
_version_ 1782384364205637632
author Hamo, Carine E
Bloom, Michelle Weisfelner
author_facet Hamo, Carine E
Bloom, Michelle Weisfelner
author_sort Hamo, Carine E
collection PubMed
description With the improvement in cancer survival, long-term cardiotoxicity has become an area of increased interest. Various cancer therapies, including chemotherapy and radiation therapy can lead to cardiac toxicities with both acute and chronic manifestations. Awareness and early recognition can lead to improvement in cardiac survival and patient outcomes. The focus of this review is to summarize the cancer therapy agents most often associated with cardiovascular side effects, highlighting their mechanism of action and strategies for surveillance and prevention.
format Online
Article
Text
id pubmed-4525792
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-45257922015-08-25 Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy Hamo, Carine E Bloom, Michelle Weisfelner Clin Med Insights Cardiol Review With the improvement in cancer survival, long-term cardiotoxicity has become an area of increased interest. Various cancer therapies, including chemotherapy and radiation therapy can lead to cardiac toxicities with both acute and chronic manifestations. Awareness and early recognition can lead to improvement in cardiac survival and patient outcomes. The focus of this review is to summarize the cancer therapy agents most often associated with cardiovascular side effects, highlighting their mechanism of action and strategies for surveillance and prevention. Libertas Academica 2015-08-02 /pmc/articles/PMC4525792/ /pubmed/26309419 http://dx.doi.org/10.4137/CMC.S19704 Text en © 2015 the author(s), publisher and licensee Libertas Academica Ltd. This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 license.
spellingShingle Review
Hamo, Carine E
Bloom, Michelle Weisfelner
Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy
title Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy
title_full Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy
title_fullStr Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy
title_full_unstemmed Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy
title_short Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy
title_sort getting to the heart of the matter: an overview of cardiac toxicity related to cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525792/
https://www.ncbi.nlm.nih.gov/pubmed/26309419
http://dx.doi.org/10.4137/CMC.S19704
work_keys_str_mv AT hamocarinee gettingtotheheartofthematteranoverviewofcardiactoxicityrelatedtocancertherapy
AT bloommichelleweisfelner gettingtotheheartofthematteranoverviewofcardiactoxicityrelatedtocancertherapy